Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Planning your retirement portfolio at 40? Discover essential assets to include for a balanced and secure financial future.
20,742 articlesA major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...
ConocoPhillips announces a strategic pivot from growth to cash harvesting as it completes the Marathon Oil deal and b...
A major cold storage leader caught the eye of a notable investor, who disclosed a fresh stake worth $19 million. This...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
When headlines talk about a stock suddenly bleeding, traders worry about customer losses and slowing growth. This art...
Gold retreats while Bitcoin-focused ETFs keep drawing capital, highlighting a widening split in how investors price i...
Investors have watched Micron stock keep going lower despite upbeat earnings. This deep dive explains the forces behi...
Investing hinges on leadership as much as numbers. This guide dives into how Josh D'Amaro's new approach could influe...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
Fresh analyst calls are steering the early-week mood on Wall Street. Dell Technologies, BioMarin, Disney, HubSpot and...
Shaquille O’Neal credits a small, selfless moment from his father with shaping his approach to money, business, and g...